AEMETIS, INC
No SEC Form 4 filings for $AMTX in the last 30 days.
Simply Wall St reports Aemetis (AMTX) shares rose 5.5% to $1.72 after its Q2 release. Q2 revenue rose to $62.7m from $52.2m. The company swung to operating income of $5.8m from an operating loss, while net loss narrowed to $9.4m. The article cites $1m cash and ongoing liquidity and policy execution risks.
Aemetis Inc. reported Q2 2026 revenue of $62.7 million, up 20% year over year but below the $69.89 million forecast. The company posted an adjusted loss of 13 cents per share versus a 26-cent expected loss, with operating income improving to $5.8 million. It cited Section 45Z credit monetization and expects MVR-related cash flow.
Aemetis reported Q2 2026 revenue of $62.7 million, up $10.5 million (20%) from Q2 2025, including $8.6 million from Section 45Z tax credits. Operating income improved by $16.4 million, net loss narrowed to $9.4 million, and adjusted EBITDA rose to $9.7 million. The company is pursuing refinancing and financing for its Keyes ethanol and Dairy RNG projects, and is considering an IPO for its India unit.
Over the past 7 days, alphai's AI scored 5 news stories mentioning AMTX (AEMETIS, INC). Coverage has skewed bullish: 2 bullish, 3 neutral, and 0 bearish.
Recent AMTX coverage spans earnings, financial news and corporate actions.
The article frames a near-term relief trade on the operating-profit swing, but highlights persistent liquidity risk from only $1m cash and ongoing net losses.
Mixed quarter results likely keep AMTX’s turnaround narrative intact on profitability, while the revenue miss and $1M cash raise near-term financing risk.
Results show improving profitability metrics, but the balance sheet remains highly leveraged with major refinancing and funding needs.
Q2 earnings show material improvement driven by production tax credits and RNG/ethanol execution, but cash remains low and interest expense is heavy.
The India biodiesel supply deal is a near-term revenue catalyst and supports incremental order expectations into 2026.
alphai scores every news story that mentions AMTX with an AI model for sentiment and relevance, and aggregates insider trades from AEMETIS, INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Simply Wall St reports Aemetis (AMTX) shares rose 5.5% to $1.72 after its Q2 release. Q2 revenue rose to $62.7m from $52.2m. The company swung to operating income of $5.8m from an operating loss, while net loss narrowed to $9.4m. The article cites $1m cash and ongoing liquidity and policy execution risks.
4 min readAemetis Inc. reported Q2 2026 revenue of $62.7 million, up 20% year over year but below the $69.89 million forecast. The company posted an adjusted loss of 13 cents per share versus a 26-cent expected loss, with operating income improving to $5.8 million. It cited Section 45Z credit monetization and expects MVR-related cash flow.
6 min readAemetis reported Q2 2026 revenue of $62.7 million, up $10.5 million (20%) from Q2 2025, including $8.6 million from Section 45Z tax credits. Operating income improved by $16.4 million, net loss narrowed to $9.4 million, and adjusted EBITDA rose to $9.7 million. The company is pursuing refinancing and financing for its Keyes ethanol and Dairy RNG projects, and is considering an IPO for its India unit.
7 min readAEMETIS, INC (AMTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_998023.htm EXHIBIT 99.1 AEMETIS Q2'2026 EARNINGS ex_998023.htm Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.com Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 investors@aemeti
6 min readAemetis Inc (NASDAQ:AMTX) shares rose 4.3% after its India unit, Universal Biofuels, secured about $17 million in biodiesel supply contracts. Over three months it will deliver more than 18 million liters to India’s three government-owned Oil Marketing Companies, supporting a policy to raise biodiesel blending to 5% by 2030. Additional orders are expected through 2026.
3 min readIATA says SAF is 0.6% of jet fuel use versus a 65% net-zero target by 2050, and SAF costs 2 to 5 times more than conventional fuel. A report by IECC at UC Berkeley and Energy Innovation says India could produce SAF via PBtL at up to 40% below global benchmarks, targeting $9B exports by 2030 and $30B by 2040. Aemetis (AMTX) is exploring an IPO for its India unit.
7 min readAemetis, Inc. (NASDAQ: AMTX) said its ethanol and renewable natural gas subsidiaries received about $18 million from selling Section 45Z Clean Fuel Production Tax Credits. It included $6 million from 2025 ethanol and $12 million from year-to-date 2026 ethanol and RNG, with net proceeds of about $14.5 million after costs.
4 min readAemetis, Inc. (NASDAQ: AMTX) said its ethanol and renewable natural gas subsidiaries received about $18 million from selling Section 45Z Clean Fuel Production Tax Credits. It includes $6 million from 2025 ethanol and $12 million from 2026 year-to-date ethanol and RNG. Net cash proceeds were about $14.5 million after costs.
4 min readAemetis, through its subsidiary Aemetis Biogas, has amended its Series A Preferred Unit Purchase Agreement with Protair-X Technologies and Third Eye Capital. This amendment extends the redemption deadline for all outstanding Series A Preferred Units to April 30, 2026, setting the aggregate redemption price at $114.7 million, which includes a $2 million amendment fee. Should the units not be redeemed by this new date, Aemetis Biogas will enter into a new credit agreement, effective May 1, 2026, with a maturity of May 1, 2027, bearing an interest rate of 16.0% or prime plus 10.0%, whichever is greater.
2 min readAemetis to Review Third Quarter 2025 Financial Results on November ...
3 min read
